Full-Time

Principal Scientist

Biopharma Ligand Binding Assays

KCAS Bio

KCAS Bio

201-500 employees

GLP/GCP bioanalytical & biomarker CRO services

Compensation Overview

$106k - $140k/yr

Kansas City, MO, USA

In Person

Category
Biology & Biotech (1)

Get referred to KCAS Bio

See people who can refer or advise you

Requirements
  • At least six years of relevant experience within contract research, academic or pharmaceutical industry, including expertise in the core competencies of validation and bioanalysis of study samples. Also requires a full understanding of GLPs, and departmental/company SOPs.
  • Experience designing, planning, and executing bioanalytical assays (ADA, PK, Biomarker and Nab), method development and validation.
  • Proficient in using common immunoassay platforms (ELISA, MSD, Luminex, etc.)
  • Experience designing complex experiments & evaluating outcome vs. regulatory guidelines, white papers, and current industry practices.
  • Experience troubleshooting problems and actively participating in the life cycle management of assays.
  • Ability to manage multiple moderate to highly complex projects, prioritizes work, and meets deadlines.
  • Capable of anticipating and recognizing potential problems within programs and effectively communicate alternatives to clients in a meaningful fashion.
  • Must have proven record of delivering quality service to customers on time and on budget.
  • Expert knowledge of applicable lab techniques.
  • Familiarity with current industry trends and expectations.
  • Demonstrated proficiency with validation, experimental design, troubleshooting, and method development as required by department.
Responsibilities
  • Function independently as a Principal Scientist and technical expert in the direction and execution of bioanalytical validations and biostudies as required.
  • Provide oversight of the laboratory and mentor research staff in areas such as protocol interpretation, method development and refinement, study-related problem resolution, and technique validation, as well as providing scientific expertise in study design, conduct, and interpretation.
  • Independently review, interpret, analyze, evaluate, and discuss study results with research staff and Sponsors.
  • Prepare high-quality final reports appropriate for the study, including integration of supporting subcontractor(s)’ reports into final reports as required.
  • Supervise research and scientific staff within the function.
  • Direct activities of assigned group(s), to ensure effective performance of function.
  • Review protocols, reports, and scientific documents of direct reports as required.
  • Provide scientific and technical leadership within the designated business unit to resolve analytical challenges in a timely fashion, and to evaluate new technologies for potential integration into the existing portfolio of services.
  • Provide direct daily supervision and review the work of assigned departmental employees, to ensure scientific accuracy and adherence to departmental policies, practices, and procedures. Schedule and prioritize direct reports' workload.
  • Ensure effective communication within departmental groups, to provide overlap of diverse expertise. Implement techniques to improve productivity, increase efficiencies, and maintain state-of-the-art practices.
  • Monitor and increase the technical performance and expertise of departmental direct reports through coaching and mentoring. Prepare and deliver salary and performance reviews; review and approve salary appraisals initiated by direct reports.
  • Attend scientific meetings, conferences, and training courses to enhance job and professional skills. Present abstracts/posters at national meetings, when appropriate, to maintain a scientific presence and visibility in areas of individual expertise.
  • Ensure that reports, raw data specimens, and supporting study documentation are transferred to the archives at the close of each study.
  • Ensure effective communication within departmental groups to provide expertise in Sponsor calls, presentation materials, and pricing information.
  • Perform other related duties as assigned.

KCAS Bio is a full-service bioanalytical and biomarker contract research organization (CRO) that supports pharmaceutical, biotechnology, and academic clients by delivering GLP- and GCP-compliant development services for drugs, biologics, and cell/gene therapies. The company operates on a contract-based model, providing flexible, expert teams and scalable capacity to meet each project’s needs. Its workflow involves conducting bioanalytical assays and biomarker work within regulated frameworks, acting as an extension of clients’ laboratories to enable rapid, scientifically rigorous research. KCAS Bio differentiates itself through a collaborative culture, continuous learning, and a commitment to speed and adaptability, focusing on delivering high-quality results efficiently. The company’s goal is to help clients advance time-critical research and bring new therapies through development and regulatory stages quickly and confidently.

Company Size

201-500

Company Stage

Seed

Total Funding

$250K

Headquarters

Shawnee, Kansas

Founded

1979

Get referred to KCAS Bio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • KCAS Bio is present at eight major 2026 conferences, driving pipeline visibility.
  • March 2026 GLP renewal supports near-term European preclinical demand and repeat client retention.
  • Expanding flow cytometry, immunogenicity, and biomarker platforms deepens wallet share in advanced therapies.

What critics are saying

  • Charles River and Labcorp pressure pricing by bundling bioanalysis into broader development contracts.
  • Any GLP lapse in Lyon would freeze IND-enabling work and damage sponsor trust.
  • AI-enabled flow cytometry promises efficiency; if execution slips, clients defect during 2026 launches.

What makes KCAS Bio unique

  • Only select CRO offering both large- and small-molecule bioanalysis with biomarker services.
  • Lyon renewed GLP compliance in March 2026, strengthening regulated IND-enabling credibility.
  • Crux Biolabs alliance gives harmonized spectral flow cytometry across U.S., Europe, Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Professional Development Budget

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

30%

1 year growth

30%

2 year growth

30%
KCAS Bio
Jul 27th, 2026
World Vaccine Congress Europe.

World Vaccine Congress Europe. October 19 2026 - October 21 2026 KCAS Bio at the World Vaccine Congress - Europe 2026. KCAS Bio is thrilled to announce its participation in the World Vaccine Congress Europe, taking place in Amsterdam, Netherlands, from October 19-21. This event gathers the world's leading vaccine research, development, and manufacturing experts to share groundbreaking insights and advancements. Kcas, Llc is excited to join this dynamic forum and showcase its exceptional bioanalytical capabilities. At KCAS Bio, Kcas, Llc is dedicated to advancing vaccine development through its expertise in bioanalytical services. Its team of highly skilled scientists provides precise and reliable data to support all stages of vaccine research and development. From immunogenicity testing and neutralizing antibody assays to biomarker analysis and stability testing, its comprehensive suite of services ensures the highest standards of accuracy and efficiency. Its state-of-the-art laboratory facilities are equipped with the latest technologies to meet the evolving needs of the vaccine industry. Let's connect. Contact KCAS Bio to schedule a meeting at the World Vaccine Congress Europe. Let's discuss your project needs and explore how its innovative services can drive your success. Reach out to Kcas, Llc today or directly to Charisse Fernandez. Date: October 19 - October 21 Address: RAI Amsterdam Convention Centre, Amsterdam Add to calendar: Meet Kcas, Llc at this event By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Jul 27th, 2026
Festival of Biologics 2026.

Festival of Biologics 2026. October 13 2026 - October 15 2026 Join KCAS Bio at the 2026 Festival of Biologics, taking place from October 13-15 in Basel, Switzerland. This festival, hosted by Terrapinn, brings together global stakeholders across pharma, biotech, academia, regulation, and investment to explore the discovery, development, manufacturing and commercialization of biologic therapies. During presentations, panels, workshops, and roundtables, experts will share insights on antibody therapies, cell and gene therapies, immunotherapies, and biosimilars. The event will foster in-depth conversations on cutting-edge developments in this field. Driving innovation in biologics at KCAS Bio. KCAS Bio is an industry leader across the biologics and advanced therapies landscape, delivering services that bring complex large molecule therapies to life. Its antibody drug conjugates, cell and gene therapies, immunotherapies, and other biologics expertise supports clients' endeavors from early discovery through clinical development. Kcas, Llc provide integrated bioanalytical, biomarker, and cell-based assay services that address the scientific and logistical challenges of modern therapeutic development, helping programs advance efficiently with confidence. As the industry evolves, Kcas, Llc remain committed to enabling progress through adaptable, science-driven solutions at every stage of the therapeutic lifecycle. Let's connect at the Festival of Biologics 2026. Kcas, Llc invite you to connect with Kcas, Llc throughout the festival. Gregoire Tauveron, Ph.D. is prepared to engage in discussions on any stage of therapeutic drug development. Date: October 13 - October 15 Address: Hall 1, Messe Basel Basel, Switzerland Add to calendar: Meet Kcas, Llc at this event By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Jul 21st, 2026
ESCGT Annual Congress.

ESCGT Annual Congress. October 27 2026 - October 30 2026 KCAS Bio at the 33rd ESCGT Annual Congress. KCAS Bio will be attending the ESGCT 33rd Annual Congress on October 27th-30th in Hamburg, Germany. Held in collaboration with DG-GT, this congress brings together experts, researchers, and professionals in gene and cell therapy to share the latest research, advancements, and innovations in the field. This event is a valuable opportunity to connect with the broader cell and gene therapy community and discuss emerging science shaping the sector. Let's connect. Heading to Hamburg for ESGCT? Let's connect - get in touch to set up a meeting with its team while Kcas, Llc is both there. you can use the contact form or directly reach out to Charisse Fernandez. Kcas, Llc look forward to meeting you in Hamburg. Date: October 27 - October 30 Address: CHH - Congress Center Hamburg Congressplatz 1 20355 Hamburg Germany Add to calendar: Meet Kcas, Llc at this event

KCAS Bio
Jul 21st, 2026
19th EBF Open Symposium.

19th EBF Open Symposium. November 17 2026 - November 19 2026 KCAS Bio will be at the 19th EBF Open Symposium: "Fearless Science. Driven by Curiosity - Guided by Data" Connecting with the bioanalytical community. Like every year, its team will be on site to reconnect with the with the bioanalytical community, exchange ideas, and discuss the latest developments in bioanalysis. Kcas, Llc look forward to engaging with the community, understanding emerging needs, and exploring how Kcas, Llc can help accelerate drug development projects. Meet its team at booth B14. Its team (Magali Roche, PhD Sr. Director, Key Accounts; Christine Bain, PhD, Senior Scientific Advisor; Cendrine Josson, Director, Operations; and Mouhssin Oufir, PhD, General Manager) will be at booth B14, showcasing its full range of bioanalytical services, sharing insights from recent projects, and highlighting how its expertise can support the advancement of complex drug development programs. Its team looks forward to another inspiring edition of the EBF Open Symposium, reflecting its passion for innovation in bioanalysis and its dedication to advancing new therapies. Date: November 17 - November 19 Address: Hyatt Regency Barcelona Tower, Barcelona - Spain Gran Via 144, L'Hospitalet de Llobregat - 08907 Barcelona, Spain Add to calendar: Meet Kcas, Llc at this event

KCAS Bio
Jul 21st, 2026
PharmaLab Congress 2026.

PharmaLab Congress 2026. November 23 2026 - November 25 2026 KCAS Bio at PharmaLab Congress. KCAS Bio will be attending the PharmaLab Congress on November 23rd-25th in Darmstadt, Germany. This annual congress brings together laboratory professionals across analytics, bioanalytics, and microbiology for three days of scientific content, parallel conference tracks, and an accompanying trade exhibition. The event offers a strong platform to connect with peers focused on laboratory optimization, bioanalytical control, and emerging regulatory trends. Let's Connect at ParmaLab 2026. Will you be at PharmaLab? Kcas, Llc'd love to connect and talk through your bioanalytical or laboratory testing needs - reach out to schedule time with its team. Kcas, Llc look forward to meeting you in Darmstadt. Date: November 23 - November 25 Address: darmstadtium Wissenschafts- und Kongresszentrum Darmstadt GmbH & Co. KG Schlossgraben 1 64283 Darmstadt Add to calendar: Meet Kcas, Llc at this event